AIRSCULPT TECHNOLOGIES INC
AIRSNASDAQTrading Snapshot
- Day Range
- $1.79 β $1.82
- 52-Week Range
- $1.51 β $12.00
- Volume
- $2.52B
- Avg Volume
- $1.98B
- Shares Outstanding
- 70.5M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $152M
- Last Q Revenue
- $43M
- P/E Ratio
- -10.4
- P/S Ratio
- 0.9x
- EPS (TTM)
- $-0.17
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +4.0%
Why Investors Own AIRS
- βHigh-growth profile β revenue up +2.5% YoY with expanding US Equity exposure.
- βHealthy economics β 53% gross margin and 4% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AIRSCULPT TECHNOLOGIES INC
AIRS
StockOtter Β· stockotter.spaceAbout AIRSCULPT TECHNOLOGIES INC
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patientβs own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the companyβs body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. (βAirSculptβ or the βCompanyβ) (NASDAQ: AIRS).Β Such investors are advised to cont
Can Prisma AIRS' $100M ARR Milestone Drive PANW's AI Security Growth?
Palo Alto Networks' Prisma AIRS tops $100 million in ARR, with rapid customer adoption highlighting growing enterprise AI security demand.
AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Fraud Investigation with SBS Law
[url="]Schall, Brown and Schwartz[/url] LLP (Γ’ΒΒSBSΓ’ΒΒ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity
AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business after several quarters of declines, while expanding services aimed at patients using GLP-1 weight-loss drugs, Chief Executi
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript